Belvedere Trading »

Relmada Therapeutics shares owned by Belvedere Trading

Quarter-by-quarter ownership of Relmada Therapeutics (RLMD) shares owned by Belvedere Trading from 13F filings

Historical chart of Belvedere Trading investment in Relmada Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Relmada Therapeutics held by Belvedere Trading consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Relmada Therapeutics by Belvedere Trading

Quarter filed Position value Share count Share price at filing
2024-03-31 $147k 32k 4.65
2022-06-30 $681k 29k 23.31
2022-03-31 $1.2M 46k 26.23
2021-09-30 $247k 11k 23.09

More positions owned by Belvedere Trading

Spdr S&p 500 Etf Tr Tr Unit (SPY)
NVIDIA Corporation (NVDA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Meta Platforms Cl A Put Option (META)
Tesla Motors (TSLA)
Ishares Tr Russell 2000 Etf (IWM)
Apple (AAPL)
Amazon (AMZN)
Spdr Gold Tr Gold Shs Put Option (GLD)
Microstrategy Cl A New Put Option (MSTR)
Ishares Silver Tr Ishares (SLV)
Coinbase Global Com Cl A (COIN)
Super Micro Computer (SMCI)
Graniteshares Etf Tr 2x Long Nvda Dai Call Option (NVDL)
Etf Opportunities Trust T Rex 2x Long (NVDX)

View all positions for Belvedere Trading

Top funds holding Relmada Therapeutics

Vanguard Group
Acadian Asset Management
Parsons Capital Management
Opaleye Management
Palo Alto Investors
Franklin Resources
BlackRock
Millennium Management
Two Sigma Advisers
Geode Capital Management
Two Sigma Investments
Deutsche Bank Aktiengesellschaft
Bank of America Corporation
Marshall Wace
Bridgeway Capital Management

View all funds holding Relmada Therapeutics